Delivery Order SPE2DB22D3301-SPE2DB24FZ1GL
Award Date
7/23/24
Potential Completion Date
7/24/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,772.85, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Losartan-HCTZ 100-12.5 mg Tablets in 90-count packages. This is a firm fixed-price delivery order contract with a completion date of September 19, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded several indefinite delivery contracts (IDCs) from the DLA and the Department...
This federal contract award, valued at $27,707.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. No set-aside designation is mentioned. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This federal contract award, valued at $7,105.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The award is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. (doing business as Amerisourcebergen) holds with the DLA Troop Support Medical....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,333.04 firm-fixed price delivery order is for 4,564,956,350 units of the medication Losartan-HCTZ 100-12.5 mg tablets. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,417.94 firm fixed price delivery order is for the supply of Losartan-HCTZ 100-25 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price, valued at $7,730.01, for the delivery of Losartan-HCTZ 100-12.5 mg tablets. The contract has a period of performance through June 3, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,403.12, is for the delivery of 4566450300 - LOSARTAN-HCTZ 100-25 MG TAB 90S, a cardiovascular medication, with a completion date of November 18, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,145.29, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4562643837 - LOSARTAN-HCTZ 50-12.5 MG TAB 1000S, with an ultimate completion date of October 31, 2023. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Losartan-HCTZ 100-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for a fixed price of $19,370.98. The contract has an ultimate completion date of August 27, 2024 and is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The IDC is with the DLA Troop...
This federal contract award, valued at $7,575.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of Losartan-HCTZ 100-12.5 mg tablets, a cardiovascular medication. No set-aside designation was used for this award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...